Screener
Stoke Therapeutics, Inc. STOK Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211874
FAQ
- What is Stoke Therapeutics, Inc.'s free cash flow?
- Stoke Therapeutics, Inc. (STOK) reported free cash flow of -$60.94M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s free cash flow changed year-over-year?
- Stoke Therapeutics, Inc.'s free cash flow decreased by 146.3% year-over-year, from $131.68M to -$60.94M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2024), Stoke Therapeutics, Inc.'s free cash flow has grown at a 8.5% compound annual growth rate (CAGR), from -$68.11M to -$87.05M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Stoke Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude